These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 32030506)

  • 1. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.
    Crinò A; Grugni G
    Curr Diab Rep; 2020 Feb; 20(2):7. PubMed ID: 32030506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
    Höybye C
    Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome.
    Krochik AG; Ozuna B; Torrado M; Chertkoff L; Mazza C
    J Pediatr Endocrinol Metab; 2006 Jul; 19(7):911-8. PubMed ID: 16995571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
    Zipf WB
    Acta Paediatr Suppl; 1999 Dec; 88(433):115-7. PubMed ID: 10626560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
    L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
    Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patients with Prader-Willi syndrome have favorable glucose metabolism?
    Qian Y; Xia F; Zuo Y; Zhong M; Yang L; Jiang Y; Zou C
    Orphanet J Rare Dis; 2022 May; 17(1):187. PubMed ID: 35525976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
    Schuster DP; Osei K; Zipf WB
    Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
    Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
    Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome in adult patients with Prader-Willi syndrome.
    Grugni G; Crinò A; Bedogni G; Cappa M; Sartorio A; Corrias A; Di Candia S; Gargantini L; Iughetti L; Pagano C; Ragusa L; Salvatoni A; Spera S; Vettor R; Chiumello G; Brambilla P
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1134-40. PubMed ID: 23220075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity.
    Lacroix D; Moutel S; Coupaye M; Huvenne H; Faucher P; Pelloux V; Rouault C; Bastard JP; Cagnard N; Dubern B; Clément K; Poitou C
    J Clin Endocrinol Metab; 2015 Mar; 100(3):850-9. PubMed ID: 25478934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prader Willi syndrome: endocrine updates and new medical therapies.
    Harris RM; Stafford DEJ
    Curr Opin Endocrinol Diabetes Obes; 2020 Feb; 27(1):56-62. PubMed ID: 31815782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity.
    Höybye C; Hilding A; Jacobsson H; Thorén M
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3590-7. PubMed ID: 12161480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
    Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
    Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
    J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects.
    Talebizadeh Z; Butler MG
    Clin Genet; 2005 Mar; 67(3):230-9. PubMed ID: 15691361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
    Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
    J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prader-Willi syndrome: endocrine manifestations and management.
    Alves C; Franco RR
    Arch Endocrinol Metab; 2020; 64(3):223-234. PubMed ID: 32555988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of obesity in Prader-Willi syndrome.
    Khan MJ; Gerasimidis K; Edwards CA; Shaikh MG
    Pediatr Obes; 2018 Jan; 13(1):3-13. PubMed ID: 27863129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.